Subscribe to be notified for updates: RSS Feed

Investor Dashboard

Featured Video

Bruno Jactel, chief executive of Tyratech, Inc. shares interim results news, including how Vamousse outperformed a recovering US head lice market in the first half of 2017.

Share Price

Symbol Name Last Price Change % Change

Symbol Name Last Price Change % Change

Recent Press Releases & RNS

2016 Annual Report

2016 Annual Report

Subscribe to Investor Alerts

Subscribe to our investor alert email service and receive notification of press releases, financial results and other key shareholder messages as soon as they become available.
  • This field is for validation purposes and should be left unchanged.


This web site contains investor-related information which is restricted to non-U.S. persons or Qualified Institutional Buyers as defined in Rule 144A of the U.S. Securities Act of 1933, as amended (the “Securities Act”). The information provided herein is not an offer to buy or sell, or a solicitation of an offer to buy or sell, any TyraTech, Inc. securities. By viewing pages on this web site, you agree and acknowledge that TyraTech, Inc.’s common stock has not been registered under the Securities Act and that you are a non-U.S. person, Qualified Institutional Buyer as defined in Rule 144A of the Securities Act., or you are not holding, acquiring or selling TyraTech, Inc. common stock for the account or benefit of any U.S. person.